Home
>
National Drug Code (NDC)
>
famotidine
famotidine - 0574-0147-04 - (famotidine)
Drug Information of famotidine
| Product NDC: | 0574-0147 |
| Proprietary Name: | famotidine |
| Non Proprietary Name: | famotidine |
| Active Ingredient(s): | 40 mg/5mL & nbsp; famotidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of famotidine
| Product NDC: | 0574-0147 |
| Labeler Name: | Paddock Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019527 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100528 |
Package Information of famotidine
| Package NDC: | 0574-0147-04 |
| Package Description: | 50 mL in 1 BOTTLE (0574-0147-04) |
NDC Information of famotidine
| NDC Code | 0574-0147-04 |
| Proprietary Name | famotidine |
| Package Description | 50 mL in 1 BOTTLE (0574-0147-04) |
| Product NDC | 0574-0147 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | famotidine |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20100528 |
| Marketing Category Name | NDA |
| Labeler Name | Paddock Laboratories, Inc. |
| Substance Name | FAMOTIDINE |
| Strength Number | 40 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
